|
GB202003678D0
|
|
Stat6 inhibiting composition
|
|
WO2020148520A1
|
|
Mesodermal killer (mk) cell
|
|
GB201916842D0
|
|
Mesodermal killer (mk) cell
|
|
GB201900554D0
|
|
Mesodermal killer (mk) cell
|
|
GB201816658D0
|
|
Mesodermal killer (MK) cell
|
|
GB201805033D0
|
|
Genetically-modified human natural killer (nk) cell
|
|
GB201805031D0
|
|
Genetically-modified human natural killer (nk) cell
|
|
GB201803436D0
|
|
Composition
|
|
GB201802162D0
|
|
Composition
|
|
GB201800817D0
|
|
Apparatus and methods for culturing adherent living cells
|
|
GB201705338D0
|
|
Genetically-modified human natural killer (NK) cell
|
|
WO2017168170A1
|
|
Immuno-modulatory progenitor (imp) cell expressing one or more of cd3, cd3e, cd8, cd8b, cd4, cd5, cd6 and cd7
|
|
GB201604476D0
|
|
Method of apparatus
|
|
GB201523058D0
|
|
Apparatus and methods for precise targeted injection of therapeutic or diagnostic agents
|
|
GB201513997D0
|
|
Immuno-Modulatory Progenitor (IMP) cell
|
|
GB201513996D0
|
|
Immuno-oncology mesodermal progenitor (IOMP) cell
|
|
GB201511459D0
|
|
Sirna microbubble
|
|
GB201504665D0
|
|
Composition
|
|
GB201410504D0
|
|
Immuno-modulaltory progenitor (IMP) cell
|
|
GB201410506D0
|
|
Hybrid composition
|
